64 related articles for article (PubMed ID: 16161077)
1. Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability.
Spilker ME; Seng KY; Yao AA; Daldrup-Link HE; Shames DM; Brasch RC; Vicini P
J Magn Reson Imaging; 2005 Oct; 22(4):549-58. PubMed ID: 16161077
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
[TBL] [Abstract][Full Text] [Related]
3. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
4. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
5. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
6. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
7. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
[TBL] [Abstract][Full Text] [Related]
8. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
[TBL] [Abstract][Full Text] [Related]
11. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
13. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
16. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
Pickup S; Chawla S; Poptani H
Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents.
Ivanusa T; Beravs K; Medic J; Sersa I; Sersa G; Jevtic V; Demsar F; Mikac U
Phys Med; 2007 Dec; 23(3-4):85-90. PubMed ID: 18061121
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
Cuenod CA; Fournier L; Balvay D; Guinebretière JM
Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
[TBL] [Abstract][Full Text] [Related]
19. MRI tumor characterization using Gd-GlyMe-DOTA-perfluorooctyl-mannose-conjugate (Gadofluorine M), a protein-avid contrast agent.
Raatschen HJ; Swain R; Shames DM; Fu Y; Boyd Z; Zierhut ML; Wendland MF; Misselwitz B; Weinmann HJ; Wolf KJ; Brasch RC
Contrast Media Mol Imaging; 2006; 1(3):113-20. PubMed ID: 17193687
[TBL] [Abstract][Full Text] [Related]
20. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
